Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04507503
Title Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements
Recruitment Approved for marketing
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Taiho Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Gilbert Arizona 85234 United States Details
University of California, San Francisco (UCSF) San Francisco California 94143 United States Details
UCLA Division of Hematology-Oncology Santa Monica California 90404 United States Details
Mount Sinai Center of Florida Miami Beach Florida 33140 United States Details
Advent Health Orlando Orlando Florida 32804 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Kansas Cancer Center Lee's Summit Missouri 64064 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
MD Anderson Houston Texas 77030 United States Details
Utah Cancer Specialists Salt Lake City Utah 84106 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Aurora Cancer care Grafton Wisconsin 53024 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field